nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—hypertension—obesity	0.42	1	CtDrD
Metoprolol—ADRB1—obesity	0.12	0.543	CbGaD
Metoprolol—ADRB2—obesity	0.101	0.457	CbGaD
Metoprolol—ADRB2—Phenylpropanolamine—obesity	0.0576	0.248	CbGbCtD
Metoprolol—ADRB1—Phenylpropanolamine—obesity	0.0567	0.244	CbGbCtD
Metoprolol—SLC22A2—Cimetidine—obesity	0.0377	0.162	CbGbCtD
Metoprolol—CYP2D6—Phentermine—obesity	0.0151	0.0652	CbGbCtD
Metoprolol—CYP2D6—Bupropion—obesity	0.0129	0.0554	CbGbCtD
Metoprolol—CYP2C19—Cimetidine—obesity	0.0124	0.0535	CbGbCtD
Metoprolol—CYP2D6—Methamphetamine—obesity	0.0121	0.0521	CbGbCtD
Metoprolol—ABCB1—Cimetidine—obesity	0.01	0.0432	CbGbCtD
Metoprolol—CYP2D6—Cimetidine—obesity	0.00945	0.0407	CbGbCtD
Metoprolol—CYP2C19—Topiramate—obesity	0.00813	0.035	CbGbCtD
Metoprolol—Alprenolol—ADRB3—obesity	0.000173	0.0571	CrCbGaD
Metoprolol—Practolol—ADRB1—obesity	0.000149	0.0491	CrCbGaD
Metoprolol—Pindolol—ADRB3—obesity	0.000149	0.0491	CrCbGaD
Metoprolol—Metipranolol—ADRB1—obesity	0.000135	0.0444	CrCbGaD
Metoprolol—Sotalol—ADRB1—obesity	0.00012	0.0396	CrCbGaD
Metoprolol—Acebutolol—SLC22A1—obesity	0.000114	0.0375	CrCbGaD
Metoprolol—Metipranolol—ADRB2—obesity	0.000114	0.0374	CrCbGaD
Metoprolol—Esmolol—ADRB1—obesity	0.000107	0.0353	CrCbGaD
Metoprolol—Bevantolol—ADRB1—obesity	0.000106	0.0349	CrCbGaD
Metoprolol—Sotalol—ADRB2—obesity	0.000101	0.0333	CrCbGaD
Metoprolol—Vomiting—Diethylpropion—obesity	9.87e-05	0.00118	CcSEcCtD
Metoprolol—Flatulence—Orlistat—obesity	9.85e-05	0.00118	CcSEcCtD
Metoprolol—Alopecia—Sibutramine—obesity	9.82e-05	0.00118	CcSEcCtD
Metoprolol—Rash—Diethylpropion—obesity	9.79e-05	0.00117	CcSEcCtD
Metoprolol—Dysgeusia—Orlistat—obesity	9.79e-05	0.00117	CcSEcCtD
Metoprolol—Dermatitis—Diethylpropion—obesity	9.78e-05	0.00117	CcSEcCtD
Metoprolol—Dizziness—Cimetidine—obesity	9.77e-05	0.00117	CcSEcCtD
Metoprolol—Headache—Diethylpropion—obesity	9.73e-05	0.00117	CcSEcCtD
Metoprolol—Rhinitis—Bupropion—obesity	9.71e-05	0.00116	CcSEcCtD
Metoprolol—Hepatitis—Bupropion—obesity	9.69e-05	0.00116	CcSEcCtD
Metoprolol—Hallucination—Bupropion—obesity	9.64e-05	0.00116	CcSEcCtD
Metoprolol—Libido decreased—Topiramate—obesity	9.62e-05	0.00115	CcSEcCtD
Metoprolol—Muscle spasms—Orlistat—obesity	9.61e-05	0.00115	CcSEcCtD
Metoprolol—Oedema peripheral—Bupropion—obesity	9.54e-05	0.00114	CcSEcCtD
Metoprolol—Hot flush—Topiramate—obesity	9.54e-05	0.00114	CcSEcCtD
Metoprolol—Flatulence—Sibutramine—obesity	9.53e-05	0.00114	CcSEcCtD
Metoprolol—Connective tissue disorder—Bupropion—obesity	9.52e-05	0.00114	CcSEcCtD
Metoprolol—Amnesia—Topiramate—obesity	9.49e-05	0.00114	CcSEcCtD
Metoprolol—Tension—Sibutramine—obesity	9.49e-05	0.00114	CcSEcCtD
Metoprolol—Dysgeusia—Sibutramine—obesity	9.47e-05	0.00114	CcSEcCtD
Metoprolol—Menopausal symptoms—Topiramate—obesity	9.45e-05	0.00113	CcSEcCtD
Metoprolol—Betaxolol—ADRB1—obesity	9.44e-05	0.0311	CrCbGaD
Metoprolol—Vision blurred—Orlistat—obesity	9.42e-05	0.00113	CcSEcCtD
Metoprolol—Visual disturbance—Topiramate—obesity	9.41e-05	0.00113	CcSEcCtD
Metoprolol—Nervousness—Sibutramine—obesity	9.39e-05	0.00113	CcSEcCtD
Metoprolol—Vomiting—Cimetidine—obesity	9.39e-05	0.00113	CcSEcCtD
Metoprolol—Atenolol—ADRB1—obesity	9.36e-05	0.0308	CrCbGaD
Metoprolol—Visual impairment—Bupropion—obesity	9.33e-05	0.00112	CcSEcCtD
Metoprolol—Rash—Cimetidine—obesity	9.32e-05	0.00112	CcSEcCtD
Metoprolol—Dermatitis—Cimetidine—obesity	9.31e-05	0.00112	CcSEcCtD
Metoprolol—Muscle spasms—Sibutramine—obesity	9.3e-05	0.00112	CcSEcCtD
Metoprolol—Headache—Cimetidine—obesity	9.26e-05	0.00111	CcSEcCtD
Metoprolol—Nausea—Diethylpropion—obesity	9.22e-05	0.00111	CcSEcCtD
Metoprolol—Chlorphenesin—CYP19A1—obesity	9.17e-05	0.0302	CrCbGaD
Metoprolol—Chlorphenesin—BCHE—obesity	9.15e-05	0.0301	CrCbGaD
Metoprolol—Hypoglycaemia—Topiramate—obesity	9.14e-05	0.0011	CcSEcCtD
Metoprolol—Bisoprolol—ADRB1—obesity	9.12e-05	0.03	CrCbGaD
Metoprolol—Vision blurred—Sibutramine—obesity	9.12e-05	0.00109	CcSEcCtD
Metoprolol—Eye disorder—Bupropion—obesity	9.05e-05	0.00109	CcSEcCtD
Metoprolol—Tinnitus—Bupropion—obesity	9.03e-05	0.00108	CcSEcCtD
Metoprolol—Esmolol—ADRB2—obesity	9.02e-05	0.0297	CrCbGaD
Metoprolol—Cardiac disorder—Bupropion—obesity	8.99e-05	0.00108	CcSEcCtD
Metoprolol—Vertigo—Orlistat—obesity	8.98e-05	0.00108	CcSEcCtD
Metoprolol—Bevantolol—ADRB2—obesity	8.91e-05	0.0293	CrCbGaD
Metoprolol—Disturbance in sexual arousal—Topiramate—obesity	8.85e-05	0.00106	CcSEcCtD
Metoprolol—Palpitations—Orlistat—obesity	8.83e-05	0.00106	CcSEcCtD
Metoprolol—Angiopathy—Bupropion—obesity	8.79e-05	0.00105	CcSEcCtD
Metoprolol—Affect lability—Topiramate—obesity	8.78e-05	0.00105	CcSEcCtD
Metoprolol—Nausea—Cimetidine—obesity	8.78e-05	0.00105	CcSEcCtD
Metoprolol—Immune system disorder—Bupropion—obesity	8.75e-05	0.00105	CcSEcCtD
Metoprolol—Mediastinal disorder—Bupropion—obesity	8.73e-05	0.00105	CcSEcCtD
Metoprolol—Vertigo—Sibutramine—obesity	8.69e-05	0.00104	CcSEcCtD
Metoprolol—Syncope—Sibutramine—obesity	8.67e-05	0.00104	CcSEcCtD
Metoprolol—Leukopenia—Sibutramine—obesity	8.66e-05	0.00104	CcSEcCtD
Metoprolol—Arrhythmia—Bupropion—obesity	8.65e-05	0.00104	CcSEcCtD
Metoprolol—Acebutolol—ADRB1—obesity	8.64e-05	0.0284	CrCbGaD
Metoprolol—Oxprenolol—ADRB1—obesity	8.57e-05	0.0282	CrCbGaD
Metoprolol—Alopecia—Bupropion—obesity	8.56e-05	0.00103	CcSEcCtD
Metoprolol—Palpitations—Sibutramine—obesity	8.55e-05	0.00103	CcSEcCtD
Metoprolol—Chest pain—Orlistat—obesity	8.51e-05	0.00102	CcSEcCtD
Metoprolol—Loss of consciousness—Sibutramine—obesity	8.5e-05	0.00102	CcSEcCtD
Metoprolol—Mental disorder—Bupropion—obesity	8.49e-05	0.00102	CcSEcCtD
Metoprolol—Anxiety—Orlistat—obesity	8.48e-05	0.00102	CcSEcCtD
Metoprolol—Mood swings—Topiramate—obesity	8.45e-05	0.00101	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	8.45e-05	0.00101	CcSEcCtD
Metoprolol—Hypertension—Sibutramine—obesity	8.35e-05	0.001	CcSEcCtD
Metoprolol—Dry mouth—Orlistat—obesity	8.32e-05	0.000998	CcSEcCtD
Metoprolol—Flatulence—Bupropion—obesity	8.31e-05	0.000997	CcSEcCtD
Metoprolol—Tension—Bupropion—obesity	8.27e-05	0.000992	CcSEcCtD
Metoprolol—Dysgeusia—Bupropion—obesity	8.26e-05	0.00099	CcSEcCtD
Metoprolol—Liver function test abnormal—Topiramate—obesity	8.24e-05	0.000988	CcSEcCtD
Metoprolol—Chest pain—Sibutramine—obesity	8.23e-05	0.000988	CcSEcCtD
Metoprolol—Arthralgia—Sibutramine—obesity	8.23e-05	0.000988	CcSEcCtD
Metoprolol—Anxiety—Sibutramine—obesity	8.21e-05	0.000984	CcSEcCtD
Metoprolol—Nervousness—Bupropion—obesity	8.19e-05	0.000982	CcSEcCtD
Metoprolol—Oedema—Orlistat—obesity	8.16e-05	0.000978	CcSEcCtD
Metoprolol—Abdominal pain upper—Topiramate—obesity	8.15e-05	0.000977	CcSEcCtD
Metoprolol—Orthostatic hypotension—Topiramate—obesity	8.15e-05	0.000977	CcSEcCtD
Metoprolol—Propranolol—ADRB3—obesity	8.14e-05	0.0268	CrCbGaD
Metoprolol—Muscle spasms—Bupropion—obesity	8.11e-05	0.000972	CcSEcCtD
Metoprolol—Breast disorder—Topiramate—obesity	8.06e-05	0.000967	CcSEcCtD
Metoprolol—Dry mouth—Sibutramine—obesity	8.05e-05	0.000966	CcSEcCtD
Metoprolol—Nervous system disorder—Orlistat—obesity	8e-05	0.000959	CcSEcCtD
Metoprolol—Confusional state—Sibutramine—obesity	7.96e-05	0.000955	CcSEcCtD
Metoprolol—Vision blurred—Bupropion—obesity	7.95e-05	0.000953	CcSEcCtD
Metoprolol—Betaxolol—ADRB2—obesity	7.94e-05	0.0261	CrCbGaD
Metoprolol—Skin disorder—Orlistat—obesity	7.92e-05	0.00095	CcSEcCtD
Metoprolol—Oedema—Sibutramine—obesity	7.89e-05	0.000947	CcSEcCtD
Metoprolol—Hyperhidrosis—Orlistat—obesity	7.89e-05	0.000946	CcSEcCtD
Metoprolol—Atenolol—ADRB2—obesity	7.87e-05	0.0259	CrCbGaD
Metoprolol—Alprenolol—ADRB1—obesity	7.84e-05	0.0258	CrCbGaD
Metoprolol—Shock—Sibutramine—obesity	7.77e-05	0.000931	CcSEcCtD
Metoprolol—Thrombocytopenia—Sibutramine—obesity	7.73e-05	0.000927	CcSEcCtD
Metoprolol—Tachycardia—Sibutramine—obesity	7.7e-05	0.000924	CcSEcCtD
Metoprolol—Bisoprolol—ADRB2—obesity	7.67e-05	0.0252	CrCbGaD
Metoprolol—Skin disorder—Sibutramine—obesity	7.67e-05	0.00092	CcSEcCtD
Metoprolol—Hyperhidrosis—Sibutramine—obesity	7.63e-05	0.000915	CcSEcCtD
Metoprolol—Pindolol—HTR1B—obesity	7.63e-05	0.0251	CrCbGaD
Metoprolol—Vertigo—Bupropion—obesity	7.58e-05	0.000909	CcSEcCtD
Metoprolol—Syncope—Bupropion—obesity	7.56e-05	0.000907	CcSEcCtD
Metoprolol—Leukopenia—Bupropion—obesity	7.55e-05	0.000905	CcSEcCtD
Metoprolol—Sweating increased—Topiramate—obesity	7.51e-05	0.000901	CcSEcCtD
Metoprolol—Angina pectoris—Topiramate—obesity	7.51e-05	0.000901	CcSEcCtD
Metoprolol—Palpitations—Bupropion—obesity	7.45e-05	0.000894	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Orlistat—obesity	7.43e-05	0.000891	CcSEcCtD
Metoprolol—Loss of consciousness—Bupropion—obesity	7.41e-05	0.000889	CcSEcCtD
Metoprolol—Insomnia—Orlistat—obesity	7.38e-05	0.000885	CcSEcCtD
Metoprolol—Hypotension—Sibutramine—obesity	7.38e-05	0.000885	CcSEcCtD
Metoprolol—Paraesthesia—Orlistat—obesity	7.32e-05	0.000878	CcSEcCtD
Metoprolol—Hypertension—Bupropion—obesity	7.28e-05	0.000873	CcSEcCtD
Metoprolol—Acebutolol—ADRB2—obesity	7.26e-05	0.0239	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—obesity	7.21e-05	0.0237	CrCbGaD
Metoprolol—Musculoskeletal discomfort—Sibutramine—obesity	7.19e-05	0.000863	CcSEcCtD
Metoprolol—Dyspepsia—Orlistat—obesity	7.18e-05	0.000861	CcSEcCtD
Metoprolol—Arthralgia—Bupropion—obesity	7.18e-05	0.000861	CcSEcCtD
Metoprolol—Chest pain—Bupropion—obesity	7.18e-05	0.000861	CcSEcCtD
Metoprolol—Anxiety—Bupropion—obesity	7.15e-05	0.000858	CcSEcCtD
Metoprolol—Insomnia—Sibutramine—obesity	7.14e-05	0.000856	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	7.13e-05	0.000855	CcSEcCtD
Metoprolol—Erectile dysfunction—Topiramate—obesity	7.1e-05	0.000852	CcSEcCtD
Metoprolol—Paraesthesia—Sibutramine—obesity	7.09e-05	0.00085	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Orlistat—obesity	7.04e-05	0.000845	CcSEcCtD
Metoprolol—Dyspnoea—Sibutramine—obesity	7.04e-05	0.000844	CcSEcCtD
Metoprolol—Photosensitivity reaction—Topiramate—obesity	7.04e-05	0.000844	CcSEcCtD
Metoprolol—Fatigue—Orlistat—obesity	7.03e-05	0.000843	CcSEcCtD
Metoprolol—Dry mouth—Bupropion—obesity	7.02e-05	0.000842	CcSEcCtD
Metoprolol—Somnolence—Sibutramine—obesity	7.02e-05	0.000842	CcSEcCtD
Metoprolol—Weight increased—Topiramate—obesity	7.02e-05	0.000842	CcSEcCtD
Metoprolol—Pain—Orlistat—obesity	6.98e-05	0.000837	CcSEcCtD
Metoprolol—Dyspepsia—Sibutramine—obesity	6.95e-05	0.000833	CcSEcCtD
Metoprolol—Confusional state—Bupropion—obesity	6.94e-05	0.000832	CcSEcCtD
Metoprolol—Pneumonia—Topiramate—obesity	6.91e-05	0.000829	CcSEcCtD
Metoprolol—Oedema—Bupropion—obesity	6.88e-05	0.000825	CcSEcCtD
Metoprolol—Depression—Topiramate—obesity	6.85e-05	0.000822	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Sibutramine—obesity	6.82e-05	0.000817	CcSEcCtD
Metoprolol—Shock—Bupropion—obesity	6.77e-05	0.000812	CcSEcCtD
Metoprolol—Pain—Sibutramine—obesity	6.75e-05	0.00081	CcSEcCtD
Metoprolol—Constipation—Sibutramine—obesity	6.75e-05	0.00081	CcSEcCtD
Metoprolol—Nervous system disorder—Bupropion—obesity	6.75e-05	0.000809	CcSEcCtD
Metoprolol—Pindolol—ADRB1—obesity	6.75e-05	0.0222	CrCbGaD
Metoprolol—Thrombocytopenia—Bupropion—obesity	6.74e-05	0.000808	CcSEcCtD
Metoprolol—Feeling abnormal—Orlistat—obesity	6.72e-05	0.000806	CcSEcCtD
Metoprolol—Tachycardia—Bupropion—obesity	6.72e-05	0.000806	CcSEcCtD
Metoprolol—Skin disorder—Bupropion—obesity	6.68e-05	0.000802	CcSEcCtD
Metoprolol—Conjunctivitis—Topiramate—obesity	6.68e-05	0.000801	CcSEcCtD
Metoprolol—Gastrointestinal pain—Orlistat—obesity	6.67e-05	0.0008	CcSEcCtD
Metoprolol—Hyperhidrosis—Bupropion—obesity	6.65e-05	0.000798	CcSEcCtD
Metoprolol—Alprenolol—ADRB2—obesity	6.6e-05	0.0217	CrCbGaD
Metoprolol—Feeling abnormal—Sibutramine—obesity	6.51e-05	0.00078	CcSEcCtD
Metoprolol—Urticaria—Orlistat—obesity	6.48e-05	0.000777	CcSEcCtD
Metoprolol—Gastrointestinal pain—Sibutramine—obesity	6.46e-05	0.000774	CcSEcCtD
Metoprolol—Abdominal pain—Orlistat—obesity	6.45e-05	0.000773	CcSEcCtD
Metoprolol—Body temperature increased—Orlistat—obesity	6.45e-05	0.000773	CcSEcCtD
Metoprolol—Hypotension—Bupropion—obesity	6.43e-05	0.000771	CcSEcCtD
Metoprolol—Agranulocytosis—Topiramate—obesity	6.42e-05	0.000769	CcSEcCtD
Metoprolol—Bradycardia—Topiramate—obesity	6.28e-05	0.000753	CcSEcCtD
Metoprolol—Urticaria—Sibutramine—obesity	6.27e-05	0.000752	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Bupropion—obesity	6.27e-05	0.000752	CcSEcCtD
Metoprolol—Body temperature increased—Sibutramine—obesity	6.24e-05	0.000748	CcSEcCtD
Metoprolol—Abdominal pain—Sibutramine—obesity	6.24e-05	0.000748	CcSEcCtD
Metoprolol—Insomnia—Bupropion—obesity	6.22e-05	0.000747	CcSEcCtD
Metoprolol—Rhinitis—Topiramate—obesity	6.19e-05	0.000742	CcSEcCtD
Metoprolol—Paraesthesia—Bupropion—obesity	6.18e-05	0.000741	CcSEcCtD
Metoprolol—Hepatitis—Topiramate—obesity	6.17e-05	0.00074	CcSEcCtD
Metoprolol—Hallucination—Topiramate—obesity	6.14e-05	0.000736	CcSEcCtD
Metoprolol—Dyspnoea—Bupropion—obesity	6.14e-05	0.000736	CcSEcCtD
Metoprolol—Somnolence—Bupropion—obesity	6.12e-05	0.000734	CcSEcCtD
Metoprolol—Oedema peripheral—Topiramate—obesity	6.08e-05	0.000729	CcSEcCtD
Metoprolol—Connective tissue disorder—Topiramate—obesity	6.06e-05	0.000727	CcSEcCtD
Metoprolol—Dyspepsia—Bupropion—obesity	6.06e-05	0.000727	CcSEcCtD
Metoprolol—Hypersensitivity—Orlistat—obesity	6.01e-05	0.000721	CcSEcCtD
Metoprolol—Visual impairment—Topiramate—obesity	5.95e-05	0.000713	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Bupropion—obesity	5.94e-05	0.000713	CcSEcCtD
Metoprolol—Fatigue—Bupropion—obesity	5.93e-05	0.000712	CcSEcCtD
Metoprolol—Constipation—Bupropion—obesity	5.88e-05	0.000706	CcSEcCtD
Metoprolol—Pain—Bupropion—obesity	5.88e-05	0.000706	CcSEcCtD
Metoprolol—Asthenia—Orlistat—obesity	5.85e-05	0.000702	CcSEcCtD
Metoprolol—Hypersensitivity—Sibutramine—obesity	5.82e-05	0.000698	CcSEcCtD
Metoprolol—Pruritus—Orlistat—obesity	5.77e-05	0.000692	CcSEcCtD
Metoprolol—Eye disorder—Topiramate—obesity	5.77e-05	0.000692	CcSEcCtD
Metoprolol—Tinnitus—Topiramate—obesity	5.75e-05	0.00069	CcSEcCtD
Metoprolol—Cardiac disorder—Topiramate—obesity	5.73e-05	0.000687	CcSEcCtD
Metoprolol—Pindolol—ADRB2—obesity	5.67e-05	0.0187	CrCbGaD
Metoprolol—Feeling abnormal—Bupropion—obesity	5.67e-05	0.00068	CcSEcCtD
Metoprolol—Asthenia—Sibutramine—obesity	5.66e-05	0.000679	CcSEcCtD
Metoprolol—Gastrointestinal pain—Bupropion—obesity	5.63e-05	0.000675	CcSEcCtD
Metoprolol—Angiopathy—Topiramate—obesity	5.6e-05	0.000672	CcSEcCtD
Metoprolol—Pruritus—Sibutramine—obesity	5.58e-05	0.00067	CcSEcCtD
Metoprolol—Diarrhoea—Orlistat—obesity	5.58e-05	0.000669	CcSEcCtD
Metoprolol—Immune system disorder—Topiramate—obesity	5.57e-05	0.000669	CcSEcCtD
Metoprolol—Mediastinal disorder—Topiramate—obesity	5.56e-05	0.000667	CcSEcCtD
Metoprolol—Urticaria—Bupropion—obesity	5.47e-05	0.000656	CcSEcCtD
Metoprolol—Alopecia—Topiramate—obesity	5.45e-05	0.000654	CcSEcCtD
Metoprolol—Abdominal pain—Bupropion—obesity	5.44e-05	0.000652	CcSEcCtD
Metoprolol—Body temperature increased—Bupropion—obesity	5.44e-05	0.000652	CcSEcCtD
Metoprolol—Mental disorder—Topiramate—obesity	5.41e-05	0.000648	CcSEcCtD
Metoprolol—Diarrhoea—Sibutramine—obesity	5.4e-05	0.000648	CcSEcCtD
Metoprolol—Dizziness—Orlistat—obesity	5.39e-05	0.000647	CcSEcCtD
Metoprolol—Flatulence—Topiramate—obesity	5.29e-05	0.000635	CcSEcCtD
Metoprolol—Tension—Topiramate—obesity	5.27e-05	0.000632	CcSEcCtD
Metoprolol—Dysgeusia—Topiramate—obesity	5.26e-05	0.000631	CcSEcCtD
Metoprolol—Dizziness—Sibutramine—obesity	5.22e-05	0.000626	CcSEcCtD
Metoprolol—Nervousness—Topiramate—obesity	5.22e-05	0.000626	CcSEcCtD
Metoprolol—Vomiting—Orlistat—obesity	5.19e-05	0.000622	CcSEcCtD
Metoprolol—Muscle spasms—Topiramate—obesity	5.16e-05	0.000619	CcSEcCtD
Metoprolol—Rash—Orlistat—obesity	5.14e-05	0.000617	CcSEcCtD
Metoprolol—Dermatitis—Orlistat—obesity	5.14e-05	0.000616	CcSEcCtD
Metoprolol—Headache—Orlistat—obesity	5.11e-05	0.000613	CcSEcCtD
Metoprolol—Hypersensitivity—Bupropion—obesity	5.07e-05	0.000608	CcSEcCtD
Metoprolol—Vision blurred—Topiramate—obesity	5.06e-05	0.000607	CcSEcCtD
Metoprolol—Vomiting—Sibutramine—obesity	5.02e-05	0.000602	CcSEcCtD
Metoprolol—Rash—Sibutramine—obesity	4.98e-05	0.000597	CcSEcCtD
Metoprolol—Dermatitis—Sibutramine—obesity	4.97e-05	0.000596	CcSEcCtD
Metoprolol—Headache—Sibutramine—obesity	4.95e-05	0.000593	CcSEcCtD
Metoprolol—Asthenia—Bupropion—obesity	4.94e-05	0.000592	CcSEcCtD
Metoprolol—Pruritus—Bupropion—obesity	4.87e-05	0.000584	CcSEcCtD
Metoprolol—Nausea—Orlistat—obesity	4.84e-05	0.000581	CcSEcCtD
Metoprolol—Vertigo—Topiramate—obesity	4.83e-05	0.000579	CcSEcCtD
Metoprolol—Syncope—Topiramate—obesity	4.82e-05	0.000578	CcSEcCtD
Metoprolol—Leukopenia—Topiramate—obesity	4.81e-05	0.000577	CcSEcCtD
Metoprolol—Palpitations—Topiramate—obesity	4.75e-05	0.000569	CcSEcCtD
Metoprolol—Loss of consciousness—Topiramate—obesity	4.72e-05	0.000566	CcSEcCtD
Metoprolol—Diarrhoea—Bupropion—obesity	4.71e-05	0.000565	CcSEcCtD
Metoprolol—Nausea—Sibutramine—obesity	4.69e-05	0.000562	CcSEcCtD
Metoprolol—Hypertension—Topiramate—obesity	4.64e-05	0.000556	CcSEcCtD
Metoprolol—Arthralgia—Topiramate—obesity	4.57e-05	0.000549	CcSEcCtD
Metoprolol—Chest pain—Topiramate—obesity	4.57e-05	0.000549	CcSEcCtD
Metoprolol—Anxiety—Topiramate—obesity	4.56e-05	0.000547	CcSEcCtD
Metoprolol—Dizziness—Bupropion—obesity	4.55e-05	0.000546	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	4.54e-05	0.000545	CcSEcCtD
Metoprolol—Dry mouth—Topiramate—obesity	4.47e-05	0.000536	CcSEcCtD
Metoprolol—Confusional state—Topiramate—obesity	4.42e-05	0.00053	CcSEcCtD
Metoprolol—Oedema—Topiramate—obesity	4.38e-05	0.000526	CcSEcCtD
Metoprolol—Vomiting—Bupropion—obesity	4.38e-05	0.000525	CcSEcCtD
Metoprolol—Rash—Bupropion—obesity	4.34e-05	0.00052	CcSEcCtD
Metoprolol—Dermatitis—Bupropion—obesity	4.34e-05	0.00052	CcSEcCtD
Metoprolol—Shock—Topiramate—obesity	4.31e-05	0.000517	CcSEcCtD
Metoprolol—Headache—Bupropion—obesity	4.31e-05	0.000517	CcSEcCtD
Metoprolol—Nervous system disorder—Topiramate—obesity	4.3e-05	0.000516	CcSEcCtD
Metoprolol—Thrombocytopenia—Topiramate—obesity	4.29e-05	0.000515	CcSEcCtD
Metoprolol—Tachycardia—Topiramate—obesity	4.28e-05	0.000513	CcSEcCtD
Metoprolol—Skin disorder—Topiramate—obesity	4.26e-05	0.000511	CcSEcCtD
Metoprolol—Hyperhidrosis—Topiramate—obesity	4.24e-05	0.000508	CcSEcCtD
Metoprolol—Chlorphenesin—PTGS2—obesity	4.22e-05	0.0139	CrCbGaD
Metoprolol—Propranolol—HTR1B—obesity	4.16e-05	0.0137	CrCbGaD
Metoprolol—Hypotension—Topiramate—obesity	4.1e-05	0.000491	CcSEcCtD
Metoprolol—Nausea—Bupropion—obesity	4.09e-05	0.00049	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Topiramate—obesity	3.99e-05	0.000479	CcSEcCtD
Metoprolol—Insomnia—Topiramate—obesity	3.97e-05	0.000476	CcSEcCtD
Metoprolol—Paraesthesia—Topiramate—obesity	3.94e-05	0.000472	CcSEcCtD
Metoprolol—Dyspnoea—Topiramate—obesity	3.91e-05	0.000469	CcSEcCtD
Metoprolol—Somnolence—Topiramate—obesity	3.9e-05	0.000467	CcSEcCtD
Metoprolol—Dyspepsia—Topiramate—obesity	3.86e-05	0.000463	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Topiramate—obesity	3.79e-05	0.000454	CcSEcCtD
Metoprolol—Fatigue—Topiramate—obesity	3.78e-05	0.000453	CcSEcCtD
Metoprolol—Pain—Topiramate—obesity	3.75e-05	0.00045	CcSEcCtD
Metoprolol—Constipation—Topiramate—obesity	3.75e-05	0.00045	CcSEcCtD
Metoprolol—Propranolol—ADRB1—obesity	3.68e-05	0.0121	CrCbGaD
Metoprolol—Feeling abnormal—Topiramate—obesity	3.61e-05	0.000433	CcSEcCtD
Metoprolol—Gastrointestinal pain—Topiramate—obesity	3.59e-05	0.00043	CcSEcCtD
Metoprolol—Urticaria—Topiramate—obesity	3.48e-05	0.000418	CcSEcCtD
Metoprolol—Body temperature increased—Topiramate—obesity	3.47e-05	0.000416	CcSEcCtD
Metoprolol—Abdominal pain—Topiramate—obesity	3.47e-05	0.000416	CcSEcCtD
Metoprolol—Hypersensitivity—Topiramate—obesity	3.23e-05	0.000387	CcSEcCtD
Metoprolol—Asthenia—Topiramate—obesity	3.15e-05	0.000377	CcSEcCtD
Metoprolol—Pruritus—Topiramate—obesity	3.1e-05	0.000372	CcSEcCtD
Metoprolol—Propranolol—ADRB2—obesity	3.09e-05	0.0102	CrCbGaD
Metoprolol—Diarrhoea—Topiramate—obesity	3e-05	0.00036	CcSEcCtD
Metoprolol—Dizziness—Topiramate—obesity	2.9e-05	0.000348	CcSEcCtD
Metoprolol—Vomiting—Topiramate—obesity	2.79e-05	0.000334	CcSEcCtD
Metoprolol—Rash—Topiramate—obesity	2.76e-05	0.000332	CcSEcCtD
Metoprolol—Dermatitis—Topiramate—obesity	2.76e-05	0.000331	CcSEcCtD
Metoprolol—Headache—Topiramate—obesity	2.75e-05	0.000329	CcSEcCtD
Metoprolol—Nausea—Topiramate—obesity	2.6e-05	0.000312	CcSEcCtD
Metoprolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	3.54e-06	8.7e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CPT1A—obesity	3.51e-06	8.65e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CETP—obesity	3.51e-06	8.63e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	3.5e-06	8.62e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKR1C3—obesity	3.49e-06	8.6e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LPL—obesity	3.49e-06	8.59e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AGT—obesity	3.47e-06	8.55e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SDC1—obesity	3.47e-06	8.53e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FOXO1—obesity	3.46e-06	8.53e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	3.46e-06	8.51e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NAMPT—obesity	3.45e-06	8.48e-05	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	3.44e-06	8.47e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SCARB1—obesity	3.44e-06	8.47e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LIPC—obesity	3.43e-06	8.43e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCK—obesity	3.43e-06	8.43e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	3.42e-06	8.43e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKR1C3—obesity	3.41e-06	8.4e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOC3—obesity	3.4e-06	8.38e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—obesity	3.4e-06	8.38e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.39e-06	8.35e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAV1—obesity	3.37e-06	8.3e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOA1—obesity	3.36e-06	8.28e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SCARB1—obesity	3.36e-06	8.27e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—obesity	3.35e-06	8.25e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SREBF1—obesity	3.34e-06	8.22e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CETP—obesity	3.3e-06	8.13e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCD—obesity	3.29e-06	8.09e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SDC1—obesity	3.27e-06	8.04e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SREBF1—obesity	3.26e-06	8.02e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GOT2—obesity	3.25e-06	8e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—obesity	3.22e-06	7.92e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCD—obesity	3.22e-06	7.91e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKR1C3—obesity	3.21e-06	7.91e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—C3—obesity	3.21e-06	7.91e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.2e-06	7.89e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—FASN—obesity	3.18e-06	7.83e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GOT2—obesity	3.17e-06	7.81e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—BCHE—obesity	3.17e-06	7.79e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SCARB1—obesity	3.16e-06	7.79e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—obesity	3.15e-06	7.75e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—C3—obesity	3.14e-06	7.73e-05	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—obesity	3.11e-06	7.65e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—FASN—obesity	3.1e-06	7.64e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—BCHE—obesity	3.09e-06	7.61e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SREBF1—obesity	3.07e-06	7.56e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CG—obesity	3.07e-06	7.56e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS2—obesity	3.06e-06	7.52e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2E1—obesity	3.05e-06	7.52e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGT—obesity	3.05e-06	7.51e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NQO1—obesity	3.02e-06	7.43e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—obesity	2.99e-06	7.36e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—obesity	2.99e-06	7.36e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS2—obesity	2.99e-06	7.36e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GOT2—obesity	2.99e-06	7.36e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGT—obesity	2.99e-06	7.35e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2E1—obesity	2.98e-06	7.34e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—obesity	2.96e-06	7.3e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CAV1—obesity	2.96e-06	7.29e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.96e-06	7.28e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOA1—obesity	2.96e-06	7.28e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NQO1—obesity	2.95e-06	7.26e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.93e-06	7.21e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—obesity	2.93e-06	7.2e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—obesity	2.93e-06	7.2e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—FASN—obesity	2.92e-06	7.2e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—obesity	2.92e-06	7.2e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—BCHE—obesity	2.91e-06	7.17e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INS—obesity	2.91e-06	7.16e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CAV1—obesity	2.9e-06	7.13e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCG—obesity	2.9e-06	7.13e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC2A4—obesity	2.9e-06	7.13e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOA1—obesity	2.89e-06	7.12e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYCS—obesity	2.86e-06	7.04e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ESR1—obesity	2.86e-06	7.03e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCG—obesity	2.83e-06	6.96e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC2A4—obesity	2.83e-06	6.96e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCB—obesity	2.82e-06	6.94e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—F2—obesity	2.82e-06	6.94e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2E1—obesity	2.81e-06	6.92e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GOT1—obesity	2.8e-06	6.9e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GGT1—obesity	2.8e-06	6.9e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ESR1—obesity	2.79e-06	6.87e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYCS—obesity	2.79e-06	6.87e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BAD—obesity	2.79e-06	6.86e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NQO1—obesity	2.78e-06	6.84e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NCOA1—obesity	2.76e-06	6.8e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—F2—obesity	2.76e-06	6.79e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCB—obesity	2.76e-06	6.79e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GOT1—obesity	2.74e-06	6.74e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GGT1—obesity	2.74e-06	6.74e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BAD—obesity	2.73e-06	6.71e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—STK11—obesity	2.72e-06	6.7e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP19A1—obesity	2.72e-06	6.7e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CD—obesity	2.7e-06	6.65e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CG—obesity	2.7e-06	6.64e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NCOA1—obesity	2.7e-06	6.64e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS1—obesity	2.67e-06	6.57e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—obesity	2.67e-06	6.56e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCG—obesity	2.66e-06	6.56e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC2A4—obesity	2.66e-06	6.56e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—STK11—obesity	2.66e-06	6.54e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP19A1—obesity	2.66e-06	6.54e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CG—obesity	2.64e-06	6.5e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYCS—obesity	2.63e-06	6.47e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS1—obesity	2.61e-06	6.42e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GGT1—obesity	2.58e-06	6.35e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GOT1—obesity	2.58e-06	6.35e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—obesity	2.57e-06	6.32e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INS—obesity	2.55e-06	6.29e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—obesity	2.55e-06	6.28e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3R1—obesity	2.55e-06	6.28e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NCOA1—obesity	2.54e-06	6.25e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—COMT—obesity	2.53e-06	6.23e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—obesity	2.51e-06	6.19e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—obesity	2.51e-06	6.19e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—STK11—obesity	2.5e-06	6.16e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP19A1—obesity	2.5e-06	6.16e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INS—obesity	2.5e-06	6.15e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GNB3—obesity	2.5e-06	6.14e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARGC1A—obesity	2.5e-06	6.14e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—obesity	2.48e-06	6.12e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—obesity	2.47e-06	6.08e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—COMT—obesity	2.47e-06	6.08e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT2—obesity	2.47e-06	6.08e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—obesity	2.46e-06	6.05e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GNB3—obesity	2.44e-06	6e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARGC1A—obesity	2.44e-06	6e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GNAS—obesity	2.43e-06	5.98e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—obesity	2.43e-06	5.97e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—obesity	2.42e-06	5.95e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT2—obesity	2.42e-06	5.95e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOB—obesity	2.38e-06	5.86e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CD—obesity	2.37e-06	5.84e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GNAS—obesity	2.37e-06	5.84e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CB—obesity	2.35e-06	5.79e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	2.35e-06	5.78e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—obesity	2.35e-06	5.78e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—obesity	2.33e-06	5.74e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—COMT—obesity	2.33e-06	5.73e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOB—obesity	2.32e-06	5.72e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CD—obesity	2.32e-06	5.71e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	2.3e-06	5.66e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNB3—obesity	2.3e-06	5.65e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARGC1A—obesity	2.3e-06	5.65e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—obesity	2.3e-06	5.65e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—obesity	2.29e-06	5.62e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TYK2—obesity	2.28e-06	5.62e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPL—obesity	2.27e-06	5.59e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RHOA—obesity	2.26e-06	5.57e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—obesity	2.24e-06	5.51e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3R1—obesity	2.24e-06	5.51e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNAS—obesity	2.24e-06	5.5e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TYK2—obesity	2.23e-06	5.5e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPL—obesity	2.22e-06	5.46e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—obesity	2.22e-06	5.46e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RHOA—obesity	2.21e-06	5.45e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3R1—obesity	2.19e-06	5.39e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—obesity	2.19e-06	5.39e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOB—obesity	2.19e-06	5.39e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—obesity	2.16e-06	5.33e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD36—obesity	2.16e-06	5.31e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	2.13e-06	5.25e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD36—obesity	2.11e-06	5.19e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPL—obesity	2.09e-06	5.14e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	2.09e-06	5.14e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MTOR—obesity	2.07e-06	5.09e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CB—obesity	2.07e-06	5.09e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—obesity	2.05e-06	5.04e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—obesity	2.04e-06	5.02e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CB—obesity	2.02e-06	4.98e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MTOR—obesity	2.02e-06	4.98e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARA—obesity	2.01e-06	4.94e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—obesity	2e-06	4.92e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD36—obesity	1.99e-06	4.89e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARA—obesity	1.96e-06	4.82e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AGT—obesity	1.94e-06	4.79e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—obesity	1.92e-06	4.73e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—obesity	1.9e-06	4.69e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AGT—obesity	1.9e-06	4.67e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—obesity	1.89e-06	4.65e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAV1—obesity	1.89e-06	4.65e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA1—obesity	1.88e-06	4.63e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—obesity	1.88e-06	4.63e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—obesity	1.88e-06	4.62e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—obesity	1.86e-06	4.58e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—obesity	1.85e-06	4.55e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARA—obesity	1.85e-06	4.54e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAV1—obesity	1.84e-06	4.53e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA1—obesity	1.84e-06	4.52e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.8e-06	4.44e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—obesity	1.8e-06	4.42e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AGT—obesity	1.79e-06	4.4e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—obesity	1.76e-06	4.33e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—obesity	1.75e-06	4.31e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK8—obesity	1.75e-06	4.3e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—obesity	1.74e-06	4.29e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAV1—obesity	1.74e-06	4.27e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA1—obesity	1.73e-06	4.26e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CG—obesity	1.72e-06	4.23e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK8—obesity	1.71e-06	4.21e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—obesity	1.71e-06	4.2e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CG—obesity	1.68e-06	4.13e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—obesity	1.66e-06	4.08e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—obesity	1.64e-06	4.03e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INS—obesity	1.63e-06	4.01e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—obesity	1.62e-06	3.99e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—obesity	1.6e-06	3.93e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—obesity	1.6e-06	3.93e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INS—obesity	1.59e-06	3.91e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CG—obesity	1.58e-06	3.89e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—obesity	1.56e-06	3.85e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—obesity	1.53e-06	3.76e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CD—obesity	1.51e-06	3.72e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—obesity	1.51e-06	3.7e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INS—obesity	1.5e-06	3.68e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—obesity	1.49e-06	3.67e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MYC—obesity	1.49e-06	3.66e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—obesity	1.48e-06	3.65e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CD—obesity	1.48e-06	3.63e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—obesity	1.46e-06	3.58e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MYC—obesity	1.45e-06	3.58e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—obesity	1.45e-06	3.57e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CA—obesity	1.43e-06	3.53e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—obesity	1.43e-06	3.51e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3R1—obesity	1.43e-06	3.51e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3R1—obesity	1.39e-06	3.43e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—obesity	1.39e-06	3.43e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CD—obesity	1.39e-06	3.42e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—obesity	1.37e-06	3.38e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CB—obesity	1.32e-06	3.24e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—obesity	1.31e-06	3.23e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3R1—obesity	1.31e-06	3.23e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—obesity	1.31e-06	3.21e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CB—obesity	1.29e-06	3.16e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—obesity	1.27e-06	3.14e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CA—obesity	1.26e-06	3.1e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CA—obesity	1.23e-06	3.04e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CB—obesity	1.21e-06	2.98e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—obesity	1.2e-06	2.95e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—obesity	1.17e-06	2.88e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—obesity	1.12e-06	2.75e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—obesity	1.09e-06	2.69e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—obesity	1.03e-06	2.53e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—obesity	1.01e-06	2.48e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CA—obesity	8.03e-07	1.98e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CA—obesity	7.84e-07	1.93e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CA—obesity	7.39e-07	1.82e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—obesity	6.56e-07	1.61e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—obesity	6.4e-07	1.58e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—obesity	6.03e-07	1.49e-05	CbGpPWpGaD
